This article is intended for neurologists, neurosurgeons, intensivists, and other specialists who care for children with traumatic brain injury.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/07. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 6/13/2008
Valid for credit through: 6/13/2009
processing....
June 13, 2008 — Hypothermia therapy initiated within 8 hours and continued for 24 hours in children with severe traumatic brain injury (TBI) to treat intracranial hypertension does not improve neurological outcome and may increase mortality, new research suggests.
In a randomized, multicenter trial, the largest study of its kind ever published and the first collaborative study of 225 children with head injury among international pediatric intensive care units, researchers found that at 6-month follow-up, 32 (31%) of the 102 children assigned to the hypothermia group had unfavorable outcomes, compared with 23 (22%) of 103 children in the normothermia group.
Mortality was also higher in subjects who received hypothermia compared with those in the normothermia group, with 23 deaths (21%) and 14 deaths (12%) respectively.
"We were surprised by this trend in increased mortality [in the hypothermia group]. It looks as though it is clinically significant, but the numbers are small and the study was not designed to look at this outcome," principal investigator James Hutchison, MD, from the Hospital for Sick Children, in Toronto, Ontario, told Medscape Neurology & Neurosurgery.
The study is published in the June 5 issue of the New England Journal of Medicine.
International Trial
According to Dr. Hutchison, the rationale for the study came from animal and human studies indicating hypothermia therapy improves survival and neurologic outcomes.
In particular, he said, a single randomized trial in adults published in 1997 that showed hypothermia therapy decreased the risk of a poor outcome in a subgroup of adults with TBI who had a Glasgow Coma Scale (GCS) score of 5 to 7 (Marion DW et al. N Engl J Med. 1997;336:540-546) provided the impetus for the current trial.
"This study had a small sample size, but it looked very promising and also at that time there hadn't been any good studies done in children," he said.
"We hypothesized that, as compared with normothermia, treatment with hypothermia for 24 hours started within 8 hours after severe TBI would reduce their risk of an unfavorable outcome at 6 months," the authors write.
The study included 225 children from 17 centers in Canada, France, and the United Kingdom. Children with severe TBI were randomly assigned to either hypothermia therapy (32.5°C for 24 hours) initiated within 8 hours after injury or to normothermia (37.0°C).
Primary Outcome
The primary outcome was the proportion of children who had an unfavorable outcome, which included severe disability, persistent vegetative state, or death, assessed by the Pediatric Cerebral Performance Category score at 6 months.
A total of 102 subjects were included in the hypothermia group and 103 were assigned to the normothermia group. Subjects were eligible if they were 1 to 17 years old and had a TBI and a GCS score of 8 or less at the accident scene or in the emergency department.
All patients had a need for mechanical ventilation and a computed tomographic (CT) scan that showed an acute brain injury.
Exclusion criteria included patients who were screened more than 8 hours after injury, those with refractory shock or with suspected brain death, nonaccidental injury, prolonged cardiac arrest at the accident scene, and high cervical spinal cord injury.
Study subjects were cooled with the use of surface cooling techniques. Esophageal temperature was maintained at a mean of 32.5°C for 24 hours. For rewarming, the temperature was increased at a rate of 0.5°C every 2 hours.
After rewarming in the hypothermia group and immediately in the normothermia group, temperature was maintained at 37°C until intracranial hypertension resolved.
More Research Required
The researchers found there was more hypotension and more vasoactive agents were administered in the hypothermia group during the rewarming period vs those in the normothermia arm.
"When your whole body is cooled and rewarmed, the blood vessels constrict and blood pressure drops, and that can be bad for the brain. Even though we had a very strict protocol that continuously monitored for this and administered boluses of fluid and medication to guard against it, it still occurred during rewarming. So I think we need to be more cautious and take a slower approach [to rewarming]," he said.
A study of hypothermia therapy in an adult TBI population published in 2001 also showed no beneficial impact on survival or functional outcomes and in fact demonstrated a higher complication rate (Clifton GL et al. N Engl J Med. 2001;344:556-563).
On the basis of these results, the investigators conclude this protocol is not warranted for the treatment of severe head injury in children, and Dr. Hutchison said more research is required.
It is possible, he added, that lowering body temperature earlier and rewarming patients at a slower rate may improve outcomes — a hypothesis that will be tested in 2 new pediatric trials that are currently enrolling patients.
In the meantime, he said, the treatment should be reserved for children with refractory intracranial hypertension.
The study was supported by the Canadian Institutes of Health Research, the Ontario Neurotrauma Foundation, the Rick Hansen Institute, the SickKids Foundation, the Physicians Services Incorporated, Fonds de la Recherche en Santé du Québec, and the Children's Hospital of Eastern Ontario Research Institute. One of the study authors has received consulting fees from Johnson & Johnson. The other study authors have disclosed no relevant financial relationships.
N Engl J Med. 2008;358:2447-2456.
Although hypothermia treatment improves survival and neurologic outcome in animal models of TBI, the effect of this therapy on outcomes in children with severe TBI is still unknown. Previous trials suggested a positive effect, but the studies were underpowered and had other methodologic limitations.
A concurrent large study in adults with severe TBI, performed by a different group, did not show meaningful benefits in the rate of survival. The investigators in the present trial hypothesized that compared with normothermia, treatment with hypothermia for 24 hours, started within 8 hours after severe TBI, would reduce the risk for an unfavorable outcome at 6 months.